Cipla - Quaterly Results

31 Oct 2025 Evaluate
The company witnessed a 9.44% growth in the revenue at Rs. 52257.20 millions for the quarter ended September 2025 as compared to Rs. 47750.30 millions during the year-ago period.Net profit showed a marginal rise at Rs. 12105.30 millions for the quarter ended September 2025, as compared to corresponding quarter of last year.OP of the company witnessed a marginal growth to 17772.90 millions from 17271.80 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 52257.20 47750.30 9.44 102718.90 92760.80 10.74 190448.50 165743.40 14.91
Other Income 2546.60 2891.40 -11.93 5257.30 5026.60 4.59 9847.20 10706.60 -8.03
PBIDT 17772.90 17271.80 2.90 36728.10 33005.60 11.28 67631.60 55548.10 21.75
Interest 26.50 30.00 -11.67 85.30 80.70 5.70 151.10 202.50 -25.38
PBDT 17746.40 17241.80 2.93 36642.80 32924.90 11.29 70427.10 55345.60 27.25
Depreciation 1413.00 1457.10 -3.03 2869.90 2835.70 1.21 5738.90 5875.90 -2.33
PBT 16333.40 15784.70 3.48 33772.90 30089.20 12.24 64688.20 49469.70 30.76
TAX 4228.10 4003.10 5.62 8636.30 7748.20 11.46 13111.70 12327.80 6.36
Deferred Tax 105.90 -64.20 -264.95 -46.30 101.70 -145.53 -491.50 60.90 -907.06
PAT 12105.30 11781.60 2.75 25136.60 22341.00 12.51 51576.50 37141.90 38.86
Equity 1615.50 1615.10 0.02 1615.50 1615.10 0.02 1615.20 1614.70 0.03
PBIDTM(%) 34.01 36.17 -5.97 35.76 35.58 0.49 35.51 33.51 5.96

Cipla Share Price

1525.60 4.40 (0.29%)
05-Dec-2025 14:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.80
Dr. Reddys Lab 1275.10
Cipla 1525.60
Zydus Lifesciences 933.55
Lupin 2101.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×